Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 90-day, Double-blind, Placebo-controlled, Randomized, Parallel-Group Efficacy and Safety Study of an Amino Acid Supplement in Adults

NCT05599282 is registered in ClinicalTrials.gov with ZandA Technologies, llc as lead sponsor.

NCT NCT05599282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05599282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 90-day, Double-blind, Placebo-controlled, Randomized, Parallel-Group Efficacy and Safety Study of an Amino Acid Supplement in Adults
Lead sponsor
ZandA Technologies, llc
Phase
Phase 2
Overall status
Completed
Start date
October 26, 2022
Completion date
January 22, 2024
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, insulin-like growth factor i